Why is SPARC falling/rising?

As of 18-Nov, Sun Pharma Advanced Research Company Ltd is experiencing a decline in its stock price, currently at 129.35, which represents a decrease of 2.25 or 1.71%. The stock has underperformed its sector by 1.09% today and has been on a consecutive downward trend for the last two days, with a total return drop of 1.97%. Additionally, the stock is trading below its moving averages across all time frames, indicating a bearish trend. The company has reported negative financial results, including a significant drop in net sales and operating profit, contributing to a negative book value and weak long-term fundamentals. The stock's performance has been consistently poor, with a year-to-date decline of 35.41% compared to a positive return of 8.36% for the benchmark.
In the broader market context, the stock's short-term performance has been notably weaker than the benchmark, with a 1-week return of -1.33% compared to the Sensex's gain of 0.96%. This underperformance is reflective of the company's ongoing struggles, including a negative EBIT to interest ratio and declining investor participation, as evidenced by a 57.61% drop in delivery volume against the 5-day average. The overall market appears to be performing better, which further highlights the challenges faced by Sun Pharma Advanced Research Company Ltd in attracting investor confidence and achieving positive growth.